Wedbush initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $16 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences initiated with an Outperform at JMP Securities
- Solid Biosciences management to meet with Piper Sandler
- Solid Biosciences announces collaboration with Mayo Clinic
- Solid Biosciences reports inducement grant under Nasdaq listing rule
- Solid Biosciences Reports Increased Losses Amid R&D Focus